Although the focus of this review is the PI3K/AKT and RUNX2 mutual activation, the integration of the TGFβ signaling pathway in this positive feedback loop further illustrates the complexity of the interactions governing tumor progression, which warrants a comparable level of complexity for the design of new treatments for cancer patients. This evidence concerns the gene RUNX2 and neoplasm.